Hair Relaxer & Uterine Cancer Risk - Episode #55

By Tamara Thomas - Last Updated: November 10, 2022
Also available on the following streaming services
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links
Additional Podcast Links

On this episode, we discuss research that says drug prices don’t reflect R&D cost; transgender men and the abortion fight; hair relaxer and uterine cancer risk; and more.

Related Podcasts

New AMA Partnership Seeks to Improve Hypertension Control in the US
Hidradenitis Suppurativa Clinical Trials Lack People of Color
Cardiovascular Health in Young Adults Has Not Improved Over the Past Decade
Women's Health
Higher Rates of Emergency Colorectal Cancer Surgery Among Blacks
Scientists Find Clue Explaining Why Alzheimer's Disease More Prevalent in Women
Advertisement
Latest News

New AMA Partnership Seeks to Improve Hypertension Control in the US

January 26, 2023

Hidradenitis Suppurativa Clinical Trials Lack People of Color

January 25, 2023

Cardiovascular Health in Young Adults Has Not Improved Over the Past Decade

January 20, 2023
Advertisement

  • 670 Madison Ave.

    Manalapan, NJ 07726

    • Who We Are

    About Us

    Editorial Policy

    Contributors & Partners

    Connect

    eNewsletters

    Contact Us

    Work With Us

    Advertising

    Our Network

    GU Oncology Now

    Blood Cancers Today

    Cancer Nursing Today

    DocWire News

    MashupMD

    © 2023 Mashup Media, LLC. All rights reserved.

    Terms of Use | Privacy Policy | v1.1